Sunny Pharmtech Inc. (6676) Stock Statistics & Valuation Metrics
Total Valuation
Sunny Pharmtech Inc. has a market cap or net worth of TWD 1.18B. The enterprise value is ―.
- Market Cap
- TWD 1.18B
- Enterprise Value
- ―
Share Statistics
Sunny Pharmtech Inc. has 169,679,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 169,679,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Sunny Pharmtech Inc.’s return on equity (ROE) is -0.40 and return on invested capital (ROIC) is -24.45%.
- Return on Equity (ROE)
- -0.40
- Return on Assets (ROA)
- -0.22
- Return on Invested Capital (ROIC)
- -24.45%
- Return on Capital Employed (ROCE)
- -0.28
- Revenue Per Employee
- 1.58M
- Profits Per Employee
- -1.89M
- Employee Count
- 160
- Asset Turnover
- 0.18
- Inventory Turnover
- 3.45
Valuation Ratios
The current PE Ratio of Sunny Pharmtech Inc. is -3.70. Sunny Pharmtech Inc.’s PEG ratio is 0.22.
- PE Ratio
- -3.70
- PS Ratio
- 5.76
- PB Ratio
- 1.49
- Price to FCF
- -7.50
- Price to Operating Cash Flow
- -8.36
- PEG Ratio
- 0.22
Income Statement
In the last 12 months, Sunny Pharmtech Inc. had revenue of 253.01M and earned -302.05M in profits. Earnings per share was -2.03.
- Revenue
- 253.01M
- Gross Profit
- -23.37M
- Operating Income
- -317.53M
- Pretax Income
- -302.05M
- Net Income
- -302.05M
- EBITDA
- -189.95M
- Earnings Per Share (EPS)
- -2.03
Cash Flow
In the last 12 months, operating cash flow was -146.02M and capital expenditures -33.13M, giving a free cash flow of -179.15M billion.
- Operating Cash Flow
- -146.02M
- Free Cash Flow
- -179.15M
- Free Cash Flow per Share
- -1.16
Dividends & Yields
Sunny Pharmtech Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -13.15%
- Earnings Yield
- -26.26%
Stock Price Statistics
- Beta
- 0.81
- 52-Week Price Change
- -50.14%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 13.72
- Average Volume (3m)
- 304.25K
Financial Position
Sunny Pharmtech Inc. as a current ratio of 0.91, with Debt / Equity ratio of 64.16%
- Current Ratio
- 0.91
- Quick Ratio
- 0.61
- Debt to Market Cap
- 0.21
- Net Debt to EBITDA
- -2.28
- Interest Coverage Ratio
- -30.65
Taxes
In the past 12 months, Sunny Pharmtech Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Sunny Pharmtech Inc. EV to EBITDA ratio is -7.20, with an EV/FCF ratio of -8.95.
- EV to Sales
- 6.87
- EV to EBITDA
- -7.20
- EV to Free Cash Flow
- -8.95
- EV to Operating Cash Flow
- -10.98
Balance Sheet
Sunny Pharmtech Inc. has TWD 94.41M in cash and marketable securities with TWD 332.42M in debt, giving a net cash position of -TWD 238.00M billion.
- Cash & Marketable Securities
- TWD 94.41M
- Total Debt
- TWD 332.42M
- Net Cash
- -TWD 238.00M
- Net Cash Per Share
- -TWD 1.40
- Tangible Book Value Per Share
- TWD 5.00
Margins
Gross margin is -6.41%, with operating margin of -150.02%, and net profit margin of -139.33%.
- Gross Margin
- -6.41%
- Operating Margin
- -150.02%
- Pretax Margin
- -139.33%
- Net Profit Margin
- -139.33%
- EBITDA Margin
- -95.46%
- EBIT Margin
- -150.02%
Analyst Forecast
The average price target for Sunny Pharmtech Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -19.58%
- EPS Growth Forecast
- -18.33%
